The Impact of Nonsteroidal Anti-Inflammatory Drugs, Beta Blockers, and Metformin on the Efficacy of Anti-PD-1 Therapy in Advanced Melanoma

医学 二甲双胍 内科学 阿司匹林 黑色素瘤 非甾体 肿瘤科 回顾性队列研究 药理学 胰岛素 癌症研究
作者
Daniel Wang,Jennifer L. McQuade,Raghunath Rajat,John Park,Shilin Zhao,Fei Ye,Kathryn E. Beckermann,Samuel M. Rubinstein,Romany Johnpulle,Georgina V. Long,Matteo S. Carlino,Alexander M. Menzies,Michael A. Davies,Douglas B. Johnson
出处
期刊:Oncologist [Wiley]
卷期号:25 (3): e602-e605 被引量:45
标识
DOI:10.1634/theoncologist.2019-0518
摘要

Abstract Anti–programmed cell death protein-1 (anti-PD-1) therapy has greatly improved outcomes of patients with melanoma; however, many fail to respond. Although preclinical studies suggest a potentially synergistic relationship with anti-PD-1 therapy and certain concurrent medications, their clinical role remains unclear. Here, we retrospectively evaluated the use of nonsteroidal anti-inflammatory drugs (NSAIDs) and other drugs in 330 patients with melanoma treated with anti-PD-1 therapy from four academic centers. In the cohort, 37% of patients used NSAIDs including aspirin (acetylsalicylic acid; ASA; 47%), cyclooxygenase (COX)-2 inhibitors (2%), and non-ASA/nonselective COX inhibitor NSAIDs (59%). The objective response rates (ORRs) were similar in patients with NSAID (43.4%) and no NSAID (41.3%) use with no significant difference in overall suvival (OS). There was a trend toward improved progression-free survival (PFS) in patients who took NSAIDs (median PFS: 8.5 vs. 5.2 months; p = .054). Most patients (71.3%) took NSAIDs once daily or as needed. Multivariate analysis did not reveal an association with NSAID use with ORR, PFS, or OS. Concurrent use of metformin or beta blockers did not affect ORR, PFS, or OS. Our study found no conclusive association of concurrent NSAID or other medication use with improved outcomes in patients with melanoma treated with anti-PD-1 therapy. Larger and more systematic analysis is required to confirm these findings.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
枯夏发布了新的文献求助10
刚刚
1秒前
2秒前
酱豆豆完成签到 ,获得积分10
3秒前
上官若男应助漂亮幻莲采纳,获得10
4秒前
张张张完成签到 ,获得积分10
5秒前
bofu发布了新的文献求助10
7秒前
乐乐应助科研通管家采纳,获得10
8秒前
情怀应助科研通管家采纳,获得10
8秒前
8秒前
8秒前
机智的傲白应助布丁果冻采纳,获得10
9秒前
wwc应助勤奋板凳采纳,获得10
9秒前
鸡鱼蚝发布了新的文献求助10
9秒前
12秒前
酷炫小馒头完成签到,获得积分10
12秒前
蒋时晏举报兮曦123求助涉嫌违规
13秒前
14秒前
小羊完成签到,获得积分10
15秒前
我真的好饿完成签到 ,获得积分10
15秒前
why完成签到,获得积分10
16秒前
细心的代天完成签到 ,获得积分10
16秒前
鸡鱼蚝完成签到,获得积分10
16秒前
John发布了新的文献求助10
16秒前
酷波er应助迷路曼雁采纳,获得10
17秒前
eternal发布了新的文献求助10
17秒前
yy家的小哥哥完成签到,获得积分10
17秒前
yoyo122发布了新的文献求助10
19秒前
布丁果冻完成签到,获得积分20
19秒前
21秒前
Dongfu_FA完成签到,获得积分10
21秒前
22秒前
bofu发布了新的文献求助10
22秒前
8R60d8应助布丁果冻采纳,获得10
22秒前
23秒前
李爱国应助伶俐绿柏采纳,获得10
24秒前
24秒前
24秒前
yoyo122完成签到,获得积分10
25秒前
27秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Effect of reactor temperature on FCC yield 2000
Very-high-order BVD Schemes Using β-variable THINC Method 1020
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
Mission to Mao: Us Intelligence and the Chinese Communists in World War II 600
The Conscience of the Party: Hu Yaobang, China’s Communist Reformer 600
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3299813
求助须知:如何正确求助?哪些是违规求助? 2934662
关于积分的说明 8470165
捐赠科研通 2608229
什么是DOI,文献DOI怎么找? 1424075
科研通“疑难数据库(出版商)”最低求助积分说明 661827
邀请新用户注册赠送积分活动 645574